Chimerically Speaking

https://is1-ssl.mzstatic.com/image/thumb/Podcasts122/v4/90/e3/ac/90e3ace8-728d-5d54-d734-d84014847e2b/mza_13757847879444255018.jpeg/600x600bb.jpg

Mohammad Alhomoud and Joshua Fein

7 episodes

9 months ago

Chimerically Speaking is the podcast where we explore latest and greatest in the world of transplantation and cellular therapy. Hosts Mohammad Alhomoud and Joshua Fein discuss recent studies and invite leaders and creative minds from aross the field to learn about their work, their ideas, and how they arrived at them.

Hosted on Acast. See acast.com/privacy for more information.

All content for Chimerically Speaking is the property of Mohammad Alhomoud and Joshua Fein and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Hosted on Acast. See acast.com/privacy for more information.

Episodes (7/7)

Chimerically Speaking

Season 2 premiere! CLL and Richter's Transformation with Dr. Adam Kittai

Dr. Adam Kittai joins us to discuss the role for cellular therapy and allogeneic transplantation in the treatment of chronic lymphocytic leukemia and Richter's transformation. We discuss his recent publication in JCO "Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation", the approval of liso-cel for CLL, and more!

Hosted on Acast. See acast.com/privacy for more information.

1 year ago

58 minutes 7 seconds

Chimerically Speaking

Episode 6 - Thinking Meta about CAR Mortality with David Cordas dos Santos and Kai Rejeski

We chat with David Cordas dos Santos and Kai Rejeski, first and last author of a major new article in Nature Medicine:

A Systematic Review and Metaanalysis of Nonrelapse Mortality after CAR T Cell Therapy.

Hosted on Acast. See acast.com/privacy for more information.

1 year ago

53 minutes 59 seconds

Chimerically Speaking

Episode 5 - Transplant Strikes Back... immediately! The ASAP trial takes on active disease

We were delighted to speak with Dr. Arjun Law (Princess Margaret Cancer Center, Toronto, ON) about the ASAP trial https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(24)00065-6/fulltext (Stelljes, Middeke, Bug et al., Lancet Haem 2024) and his thoughtful commentary https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(24)00072-3/fulltext (Law, Mattsson, Lancet Haem 2024).

Hosted on Acast. See acast.com/privacy for more information.

1 year ago

1 hour 18 minutes 20 seconds

Chimerically Speaking

To p(53) or not to p(53): interview with Dr. Mariam Nawas

What a delight to have Dr. Mariam Nawas of the University of Chicago join us for a round-up of her favorite abstracts from Tandem 2024! We also discussed her recent and controversial review "Utility or futility? A contemporary approach to allogeneic hematopoietic cell transplantation for TP53-mutated MDS/AML", which appeared in Blood Advances earlier this year.

Hosted on Acast. See acast.com/privacy for more information.

1 year ago

54 minutes 46 seconds

Chimerically Speaking

CARpe diem! Lymphoma CAR-T roundup with Dr. Sam Yamshon

Dr. Sam Yamshon, assistant professor of medicine at Weill Cornell Medicine at New York Presbyterian, joins us to chat about the most thought-provoking lymphoma CAR-T abstracts from #Tandem24.

Hosted on Acast. See acast.com/privacy for more information.

1 year ago

1 hour 2 minutes 40 seconds

Chimerically Speaking

ICAHT Take It Anymore!

We're joined 'in the studio' by our very first interview guest, our good friend, the brilliant Dr. Kai Rejeski. Kai has been at the forefront of understanding hematologic toxicity of CAR-T therapies, and speaks with us about the HEMATOTOX score, ICAHT guidelines, and the excellent coffee in San Antonio.

Hosted on Acast. See acast.com/privacy for more information.

1 year ago

1 hour 2 minutes 16 seconds

Chimerically Speaking

Episode 1! Off to Tandem 24

Welcome! This is the first episode of Chimerically Speaking. We're excited to share our love for the science and brilliant, creative community of transplantation and cellular therapy.

In this episode we'll talk about the upcoming Tandem 2024 meeting ahead of traveling to San Antonio this week. We highlight two abstracts (of so many!) that really caught our attention:

Al Malki and colleages, TSC-100/TSC-101 Ph. 1 https://tandem.confex.com/tandem/2024/meetingapp.cgi/Paper/23846

Schoettler and colleagues, TA-TMA and age https://tandem.confex.com/tandem/2024/meetingapp.cgi/Paper/22981

Hosted on Acast. See acast.com/privacy for more information.

1 year ago

23 minutes 55 seconds